Vance R. Brown serves as Senior Vice President, General Counsel, and Corporate Secretary at Boston Scientific Corporation, a global medical technology leader in the development of innovative therapies for a wide range of medical conditions. In this pivotal role, he oversees the company's worldwide legal operations, including corporate governance, regulatory compliance, mergers and acquisitions, intellectual property strategy, and litigation management. Brown provides strategic counsel to the executive leadership team and Board of Directors, ensuring alignment with legal, ethical, and business objectives while navigating complex healthcare regulations and international markets. Prior to joining Boston Scientific in 2021, Brown held senior legal positions at prominent medical device and healthcare companies. He served as Executive Vice President and General Counsel at NxStage Medical, Inc., where he led legal efforts during its acquisition by Fresenius Medical Care. Earlier in his career, he was Vice President and Associate General Counsel at Covidien plc, managing global legal functions amid significant mergers and regulatory scrutiny. Brown began his legal career at Skadden, Arps, Slate, Meagher & Flom LLP, specializing in mergers and acquisitions and corporate finance. He holds a J.D. from Harvard Law School and a B.A. from the University of Virginia. Under Brown's leadership, Boston Scientific has successfully executed high-profile acquisitions, such as the $4.2 billion purchase of BTG plc and strategic expansions into interventional oncology and neuromodulation. His expertise has been instrumental in advancing the company's compliance programs, fostering innovation while mitigating risks in a highly regulated industry. Brown's strategic acumen and collaborative approach have earned him recognition as a key architect of Boston Scientific's sustained growth and leadership in medtech.